Artiva Biotherapeutics Inc. (ARTV)

Nov 12, 2024, 4:05 PM EST - 2 months ago

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 11, 2024, 4:05 PM EST - 2 months ago

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Oct 22, 2024, 4:05 PM EDT - 3 months ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Sep 10, 2024, 4:05 PM EDT - 4 months ago

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 5 months ago

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 13, 2024, 2:14 PM EDT - 5 months ago

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Jul 22, 2024, 3:55 PM EDT - 6 months ago

Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data

Jul 20, 2024, 4:50 AM EDT - 6 months ago

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

ACTU ARDT BLMZ CON LINE OS QMMM

Jul 18, 2024, 7:08 PM EDT - 6 months ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

Jun 28, 2024, 4:57 PM EDT - 7 months ago

Autoimmune biotech Artiva Biotherapeutics refiles for a $100 million IPO, following attempt in 2021

Jun 28, 2024, 4:04 PM EDT - 7 months ago

Artiva Biotherapeutics IPO Registration Document (S-1)